DKA treatment
Reading File
Finding Sources
Searching PubMed
"diabetic ketoacidosis" AND management
Reading File
Reading File
Reading File
Here is a comprehensive overview of DKA treatment, synthesized from the Washington Manual and Rosen's Emergency Medicine:
Diabetic Ketoacidosis (DKA) — Treatment
Diagnostic Workup First
- Serum glucose, electrolytes (BMP), ketones, ABG
- CBC with differential, urinalysis, ECG
- Identify and treat the precipitating cause (infection, missed insulin, MI, etc.)
1. IV Fluids
Goal: Restore circulating volume first, then replenish total-body water deficit (typically 3–6 L in adults).
| Phase | Fluid | Rate |
|---|---|---|
| Initial (shock/severe dehydration) | 0.9% Normal Saline | 1–2 L over 1–3 h (adults); 20 mL/kg bolus (children) |
| After volume restored | 0.45% NS (or 0.9% NS if hyponatremic) | 150–500 mL/h, titrated to BP and urine output |
| When glucose ≤250–300 mg/dL | D5W/0.45% NS | Continue to prevent hypoglycemia |
- Target: urine output 1–2 mL/kg/h
- Correct no faster than 3 mOsm/kg/h to reduce risk of cerebral edema
- Balanced crystalloids (e.g., PlasmaLyte) may resolve acidosis faster than 0.9% NS (meta-analysis, PMID 38925619)
2. Insulin
Goal: Stop ketogenesis; lower glucose.
⚠️ Do NOT start insulin until potassium ≥ 3.5 mEq/L
- Bolus: 0.1 units/kg IV regular insulin
- Infusion: 0.1 units/kg/h IV regular insulin (e.g., 100 units regular insulin in 100 mL NS → run at 10 mL/h = 10 units/h)
- Target glucose drop: 50–75 mg/dL/h (2.8–4.2 mmol/L/h); avoid >100 mg/dL/h
- Continue infusion at 1–2 units/h until: HCO₃ >15 mEq/L + anion gap closed + clinical improvement
- Transitioning to subcutaneous insulin: Give basal SC insulin 2 hours before stopping the IV infusion
3. Potassium Replacement
Critical — total body potassium is always depleted in DKA, even if serum K⁺ appears normal or high (due to acidosis shifting K⁺ extracellularly).
| Serum K⁺ | Action |
|---|---|
| < 3.3 mEq/L | Hold insulin; replete K⁺ to ≥3.3 mEq/L first |
| 3.3–5.5 mEq/L | Add 20–40 mEq KCl per liter of IV fluid; start insulin |
| > 5.5 mEq/L | Do not give K⁺; monitor closely |
4. Bicarbonate
NOT routinely recommended. Consider only in:
- pH < 6.9
- HCO₃ < 5 mEq/L
- Hemodynamic instability / shock or coma
- Severe hyperkalemia with cardiac/respiratory dysfunction
If used: 50–100 mEq in 1 L of 0.45% NS over 30–60 min + add 10 mEq KCl to prevent hypokalemia; monitor arterial pH.
5. Phosphate & Magnesium
- Phosphate: Not routinely replaced; consider IV potassium phosphate if serum phosphorus < 1.0 mg/dL or patient unable to eat
- Magnesium: Correct with 1–2 g MgSO₄ if deficient (serum Mg does not reliably reflect body stores)
6. Monitoring
- Vital signs, fluid I&O hourly
- Glucose every 1 hour
- BMP (K⁺, HCO₃⁻, anion gap) every 2–4 hours
- Maintain meticulous flow sheets
- Watch for complications: cerebral edema, hypokalemia, hypoglycemia, pulmonary edema
7. Disposition
- Most adults: ICU or high-dependency unit
- Consider outpatient management in children only if: initial pH ≥7.35, HCO₃ ≥20 mEq/L, tolerating oral fluids, no underlying precipitant requiring hospitalization
8. Special Considerations
| Situation | Management |
|---|---|
| Intubation needed | Avoid if possible (high respiratory drive is compensatory); if required, maintain hyperventilation to prevent worsening acidosis |
| Hypovolemic shock | Aggressive isotonic crystalloid resuscitation before vasopressors; rule out concurrent sepsis or MI |
| SGLT2 inhibitor-induced euglycemic DKA | Glucose may be normal/near-normal; diagnosis based on ketones + acidosis |
Recent Evidence Updates
- Balanced crystalloids vs. 0.9% NS: A 2024 meta-analysis (PMID 38925619) found balanced electrolyte solutions lead to faster DKA resolution than normal saline in adults.
- Early SC basal insulin + IV infusion: A 2026 meta-analysis of RCTs (PMID 41208563) supports co-administration of early subcutaneous basal insulin with IV insulin infusion to shorten time to DKA resolution and reduce rebound ketoacidosis.
Sources: Washington Manual of Medical Therapeutics; Rosen's Emergency Medicine: Concepts and Clinical Practice
HHS treatment
Finding Sources
Searching PubMed
"hyperosmolar hyperglycemic state" AND management
Reading File
Finding Sources
Reading File
Here is a comprehensive overview of HHS treatment:
Hyperosmolar Hyperglycemic State (HHS) — Treatment
Diagnostic Criteria (for context)
- Blood glucose > 600 mg/dL (often >1000 mg/dL)
- Serum osmolality > 320 mOsmol/L
- pH > 7.3 and HCO₃ > 18 mEq/L (minimal or no ketoacidosis)
- Usually profound dehydration + altered mental status
1. IV Fluids — Primary Treatment
Fluid replacement is the cornerstone of HHS — it takes precedence over insulin.
Deficits are large: fluid losses of 8–12 L, Na losses 5–10 mmol/kg, K losses up to 7 mmol/kg — often greater than DKA.
| Phase | Fluid | Rate |
|---|---|---|
| Initial (volume resuscitation) | 0.9% NS | 1–1.5 L bolus; 2–4 L over first 2–4 h (slower than DKA if cardiac/renal comorbidities) |
| After volume restored | 0.45% NS (if Na normal/elevated) | Continue to replenish free water deficit |
| When glucose 250–300 mg/dL | D5W/0.45% NS | Prevent hypoglycemia |
- Target positive fluid balance over 24–72 hours; total replacement may reach 10–12 L
- If serum Na rises as glucose falls, do not switch to 0.45% NS — overall osmolality is still declining; continue isotonic fluid
- Fluid replacement alone will lower glucose substantially
- Caution in patients with heart failure, ischemic heart disease, or renal impairment — adjust rate accordingly
2. Potassium
- Same principles as DKA: total body K⁺ always depleted despite normal or high initial serum levels
- Do not start insulin until K⁺ ≥ 3.5 mEq/L
- Add 10–40 mEq KCl per liter of IV fluid once urine output confirmed
- Start K⁺ supplementation (40 mEq/L ready-mixed) if K⁺ < 5.5 mEq/L and patient making urine
- If K⁺ < 3.5 mEq/L: hold insulin, replete aggressively, reassess
3. Insulin — Secondary Role
Insulin plays a supporting role in HHS, unlike in DKA. Fluids come first.
- Only start after adequate fluid resuscitation is underway
- Bolus: 5–10 units IV regular insulin if glucose >600 mg/dL (smaller bolus if <600 mg/dL)
- Infusion: 0.10–0.15 units/kg/h
- Target glucose drop: max 100 mg/dL/h — avoid faster correction (risk of osmotic encephalopathy/cerebral edema)
- Add dextrose (D5W) when glucose reaches 250–300 mg/dL; reduce infusion to 1–2 units/h
- Transition to SC: Give SC basal insulin 2 hours before stopping IV infusion
4. Bicarbonate
- Not routinely recommended
- May be required if concurrent lactic acidosis is present
5. Treat the Precipitating Cause
This is critical — HHS often occurs in elderly patients with type 2 DM who have an underlying trigger:
| Common Precipitants | Action |
|---|---|
| Infection (most common) | Cultures → empiric antibiotics early |
| MI | ECG, troponins |
| Stroke/neurologic event | CT head if indicated |
| Pancreatitis | Lipase, imaging |
| GI bleeding | Assess, stabilize |
| Mesenteric thrombosis | High index of suspicion |
| Medications (steroids, diuretics, antipsychotics) | Review and adjust |
6. Monitoring
- Glucose every 30–60 min initially
- Electrolytes (K⁺, Na⁺, HCO₃⁻, osmolality) every 2–4 hours
- Fluid intake and urine output hourly
- Continuous cardiac monitoring (ICU or step-down setting)
- Meticulous flow sheets
7. Complications to Watch For
| Complication | Notes |
|---|---|
| Thromboembolic events | DVT, PE, mesenteric thrombosis, cerebral/coronary thrombosis — high risk due to hyperviscosity |
| Cerebral edema | From too-rapid osmolality correction |
| Hypokalemia | With insulin therapy |
| Hypoglycemia | With insulin therapy |
| ARDS | From aggressive fluid resuscitation or underlying illness |
| Rhabdomyolysis | Particularly in elderly or prolonged immobility |
| DIC | In severe cases |
8. Disposition
- ICU or intermediate care unit with continuous cardiac monitoring
- Mortality remains up to 20% (vs ~4% for DKA) — driven by age, comorbidities, and delayed presentation
HHS vs DKA — Key Treatment Differences
| Feature | DKA | HHS |
|---|---|---|
| Primary treatment | Insulin + fluids | Fluids first, insulin secondary |
| Fluid deficit | 3–6 L | 8–12 L |
| Fluid replacement duration | 12–24 h | 24–72 h |
| Insulin urgency | High (stops ketogenesis) | Lower (glucose corrects with fluids) |
| Bicarbonate use | Sometimes (pH <6.9) | Rarely (only if lactic acidosis) |
| Ketosis | Prominent | Absent or minimal |
Sources: Washington Manual of Medical Therapeutics; Goldman-Cecil Medicine, 2-Volume Set
This is a shared conversation. Sign in to Orris to start your own chat.